Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 2,166 ($26.99) and last traded at GBX 2,166 ($26.99), with a volume of 279808 shares traded. The stock had previously closed at GBX 2,130 ($26.55).
Hikma Pharmaceuticals Stock Performance
The firm has a fifty day simple moving average of GBX 1,978.79 and a 200-day simple moving average of GBX 1,938.65. The stock has a market cap of £4.80 billion, a price-to-earnings ratio of 3,326.15, a P/E/G ratio of 2.38 and a beta of 0.41. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.48.
About Hikma Pharmaceuticals
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- The Basics of Support and Resistance
- MP Materials: Rare Earth Elements Powering the EV Boom
- Learn Technical Analysis Skills to Master the Stock Market
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Conference Calls and Individual Investors
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
